STREAMEX CORP. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
STREAMEX CORP. (STEX) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $3.58 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-19.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2025-05-19
- STREAMEX CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was $3.58M, a 1486.28% increase year-over-year.
- STREAMEX CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was $226.00K, a 78.58% decline year-over-year.
- STREAMEX CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was $1.05M.
- STREAMEX CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2022-03-31 was -$2.99M.
- STREAMEX CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was -$48.00K.
- STREAMEX CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$167.00K.
- STREAMEX CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$11.30M.
- STREAMEX CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2021 was -$16.61M, a 202.78% decline from fiscal 2020.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|---|---|
| 2025-03-31 | $3.58M 10-Q · filed 2025-05-19 | |||||
| 2024-12-31 | -$48.00K 10-K · filed 2025-04-15 | |||||
| 2024-09-30 | $425.00K 10-Q · filed 2024-11-14 | |||||
| 2024-06-30 | $1.91M 10-Q · filed 2024-08-14 | |||||
| 2024-03-31 | $226.00K 10-Q · filed 2025-05-19 | |||||
| 2023-12-31 | -$167.00K 10-K · filed 2025-04-15 | |||||
| 2023-09-30 | $32.00K 10-Q · filed 2024-11-14 | |||||
| 2023-06-30 | $895.00K 10-Q · filed 2024-08-14 | |||||
| 2023-03-31 | $1.05M 10-Q · filed 2024-05-20 | |||||
| 2022-12-31 | -$11.30M 10-K · filed 2024-04-16 | |||||
| 2022-09-30 | -$10.77M 10-Q · filed 2023-11-14 | |||||
| 2022-06-30 | -$6.58M 10-Q · filed 2023-08-14 | |||||
| 2022-03-31 | -$2.99M 10-Q · filed 2023-05-15 | |||||
| 2021-12-31 | -$16.61M 10-K · filed 2023-03-31 | |||||
| 2021-09-30 | -$10.73M 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | -$12.76M 10-Q · filed 2022-08-15 | |||||
| 2021-03-31 | -$5.79M 10-Q · filed 2022-05-16 | |||||
| 2020-12-31 | $16.16M 10-K · filed 2022-03-31 | |||||
| 2020-09-30 | $20.64M 10-Q · filed 2021-11-15 | $20.64M 10-Q · filed 2020-11-05 | ||||
| 2020-06-30 | $24.82M 10-Q · filed 2021-08-11 | $24.82M 10-Q · filed 2020-08-06 | ||||
| 2020-03-31 | $3.39M 10-Q · filed 2020-05-11 | |||||
| 2019-12-31 | $7.66M 10-K · filed 2020-03-13 | |||||
| 2019-09-30 | $7.86M 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | $5.88M 10-Q · filed 2020-08-06 | |||||
| 2019-03-31 | $6.48M 10-Q · filed 2020-05-11 | |||||
| 2018-12-31 | $2.90M 10-K · filed 2020-03-13 | |||||
| 2018-09-30 | $5.73M 10-Q · filed 2019-10-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |